Navigation Links
Transatlantic alliance supports breast cancer research
Date:5/6/2009

Brussels, 6 May 2009 A new transatlantic alliance has formed in the global battle against breast cancer, with the US-based international grass-roots movement Susan G. Komen for the Cure giving its support to the groundbreaking IMPAKT Breast Cancer Conference, co-organized by the Breast International Group (BIG) and the European Society for Medical Oncology (ESMO).

Susan G. Komen for the Cure is the world's largest source of non-profit funds for the fight against breast cancer. To help accelerate the search for cures for breast cancer, it will fund young cancer doctors from less affluent countries to attend the IMPAKT meeting where world leaders in translational research will discuss cutting-edge treatments that are now moving from laboratories into the clinical setting. Komen will also support ESMO research fellowships in preeminent cancer centers in Western Europe to offer doctors from Eastern European countries the opportunity to learn the newest technologies and bring them back to their home institutes.

"As breast cancer knows no borders, neither can our fight to end it," said Ambassador Nancy G. Brinker, Founder of Susan G. Komen for the Cure. "And so we must work together -- as we're doing here from nearly 70 countries -- as one united global breast cancer community. We need to put cancer at the top of the global health agenda. With the resources and resolve to prevent the preventable, treat the treatable, cure the curable, and provide palliative care for those in need."

"If we can work together -- researchers, clinicians and governments -- to cooperate and collaborate, it may be possible not only to discover cures but to translate and deliver them," added Ambassador Brinker. "We must forge an approach that is not simply anti-disease, but pro-health, and not simply treatment, but prevention."

"We hope this is the beginning of a long and fruitful collaboration. Our collective impact on breast cancer research and advocacy should not be underestimated," said Annetta Hewko, Vice President of Global Strategy and Programs at Susan G. Komen for the Cure at the IMPAKT press conference.

The IMPAKT meeting brings together seven partners, representing the leading oncology, research and cancer advocacy network involved in breast cancer in Europe.

"We are very pleased that Susan G. Komen for the Cure has decided to support IMPAKT in this way," said Dr Jos Baselga, co-chair of the meeting. "Our aim is to help develop new treatments for breast cancer patients worldwide. The best hope of achieving this is by creating the largest possible network of breast cancer specialists to share their information, resources and findings."

The first IMPAKT meeting, 7-9 May 2009 in Brussels, Belgium, is designed to present and discuss advances in translational research and ways to quickly transform laboratory discoveries into tools that clinicians can use to help make decisions about the way they treat patients in their daily practice.

"With breast cancer being the most prevalent cancer in women worldwide, collaboration to fight this devastating disease is necessary," says Dr. Martine Piccart, co-Chair of the meeting. "IMPAKT fills an urgent need within the oncology community to coordinate efforts to bring the fruits of advances in science and technology to the patient's bedside."


'/>"/>

Contact: ESMO Press Office
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
2. Statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obamas Global Health Funding for FY10 as Released by the White House Tuesday, May 5, 2009
3. New International Alliance Launched to Address Urgent Needs of Palliative Care Patients Worldwide
4. AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency
5. Global AIDS Alliance Fund Welcomes Eric Goosby to Office of The Global Aids Coordinator
6. Autism Support Network and Aid for Autistic Children Foundation, Inc. Create Alliance to Help Families Affected by Autism
7. Shanghai ChemPartner and SKK Announce Strategic Alliance
8. Leading Independent Proxy Advisory Firm Supports Specialty Underwriters Alliance, Inc. in Its Proxy Contest Against Hallmark Financial Services, Inc.
9. Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan
10. TSI Healthcare and SURVE Consulting Announce a Strategic Alliance for Leadership and Business Development
11. Health Alliance Announces First Fracture Protection Program for Actonel(R) (risedronate sodium) Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient system, ... potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: